VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 51 filers reported holding VERA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,861,201 | -55.8% | 135,755 | -48.3% | 0.04% | -46.1% |
| Q2 2023 | $4,210,798 | +80.9% | 262,355 | -12.5% | 0.08% | +117.1% |
| Q1 2023 | $2,328,000 | -70.9% | 300,000 | -27.5% | 0.04% | -64.3% |
| Q4 2022 | $8,010,900 | -28.2% | 414,000 | -20.9% | 0.10% | -26.9% |
| Q3 2022 | $11,154,000 | +178.5% | 523,400 | +77.8% | 0.13% | +185.1% |
| Q2 2022 | $4,005,000 | +184.2% | 294,300 | +390.5% | 0.05% | +213.3% |
| Q1 2022 | $1,409,000 | – | 60,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $40,289,000 | 12.90% |
| Kynam Capital Management, LP | 1,522,712 | $20,724,000 | 5.29% |
| Sofinnova Investments, Inc. | 3,181,442 | $43,299,000 | 3.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,825 | $281,057,000 | 2.93% |
| Octagon Capital Advisors LP | 575,000 | $7,826,000 | 2.09% |
| Vivo Capital, LLC | 666,666 | $9,073,000 | 0.91% |
| RA Capital Management | 1,578,820 | $21,488,000 | 0.57% |
| Alphabet Inc. | 301,580 | $4,105,000 | 0.22% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $219,000 | 0.11% |
| Polar Asset Management Partners Inc. | 294,300 | $4,005,000 | 0.05% |